Longitudinal Measurements of Visual Diet in Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7-12
SponsorState University of New York College of Optometry

About this trial

Myopia is a leading cause of visual impairment worldwide, with prevalence rising rapidly among children. Growing evidence suggests that environmental and behavioral factors play a dominant role in ocular growth; however, current studies typically isolate single components of the visual environment, such as near work or light intensity, limiting investigators' understanding of how multiple visual stimuli interact within individuals over time. The retina is continuously exposed to a dynamic "visual diet," encompassing viewing distance, illuminance, spectral composition of light, and temporal viewing patterns, as well as associated visuomotor responses such as eye vergence and pupil dynamics. A critical barrier to myopia prevention is the lack of longitudinal, quantitative measurements that integrate these factors in real-world settings during childhood ocular development.

The long-term goal of this project is to prevent myopia onset and slow myopia progression through individualized, patient-centered monitoring and modification of the visual diet. The overall objective of this proposal is to longitudinally characterize visual diet and visuomotor behavior in children and to identify the most influential environmental and physiological factors driving myopia onset and progression. The investigators will conduct a 3-year longitudinal observational study enrolling 60 children aged 7-12 years, including myopic children and non-myopic children stratified by risk of myopia progression.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: 7-12 years old (inclusive)

Astigmatism of < 1.50D

Stereopsis equal or better 100 seconds of arc

Normal binocular functions.

Disqualifiers

History of refractive surgery or myopia control

Binocular abnormalities

Ocular and systemic pathologies

Developmental delay

Trial population

Participants will be selected from the Pediatric Clinic at the College and from the local community.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

60 Participants
are grouped into 2 trial groups
Group A: Myopic group
Group B: Control

Trial outcomes

Primary outcomes

1

Refractive error (D)

Measured with an autorefractor

Time frame
From enrollment to the end of the 3-year study, every 6 months
2

Axial length (mm)

Measured with a biometer

Time frame
From enrollment to the end of the 3-year study, every 6 months
3

Viewing distance (cm)

Measured using the Visual Environment Evaluation Tool (VEET). VEET contains multiple time-of-flight (ToF) infrared sensors embedded in the temple arms of the glasses.The sensors emit infrared light toward objects in front of the wearer. The device measures the time required for the reflected infrared light to return to the sensor. Using the speed of light, the system calculates the distance between the eye/glasses and the viewed object.

Time frame
From enrollment to the end of the 3-year study, every 6 months
4

Illuminance (lux)

Measured with the Visual Environment Evaluation Tool (VEET). VEET uses photometric light sensors that detect the light intensity. The sensors convert incoming light into electrical signals proportional to brightness, and the device reports illuminance in lux, the standard unit for light exposure.

Time frame
From enrollment to the end of the 3-year study, every 6 months

Secondary outcomes

1

Height (cm)

Using a stadiometer.

Time frame
From enrollment to the end of the 3-year study, every 6 months
2

Arm length (cm)

Measured using a tape measure.

Time frame
From enrollment to the end of the 3-year study, every 6 months
3

Accommodative facility

Using +/- 2.00 D flippers

Time frame
From enrollment to the end of the 3-year study, every 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.